Entity Common Stock, Shares Outstanding of Coeptis Therapeutics Holdings, Inc. from 09 Dec 2020 to 11 Nov 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Coeptis Therapeutics Holdings, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 09 Dec 2020 to 11 Nov 2025.
  • Coeptis Therapeutics Holdings, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 11 Nov 2025 was 5,340,111, a 87% decline year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Coeptis Therapeutics Holdings, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 5,340,111 -35,778,482 -87% 11 Nov 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 36,089,917 -3,628,676 -9.1% 26 May 2025 10-K/A 03 Jun 2025 2024 FY
Q1 2025 3,364,939 -32,724,978 -91% 26 Mar 2025 10-K 28 Mar 2025 2024 FY
Q3 2024 41,118,593 +7,010,557 +21% 12 Nov 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 39,718,593 +14,577,557 +58% 13 Aug 2024 10-Q 16 Aug 2024 2024 Q2
Q1 2024 36,089,917 +15,648,881 +77% 22 Mar 2024 10-K/A 16 Aug 2024 2023 FY
Q3 2023 34,108,036 08 Nov 2023 10-Q/A 16 Aug 2024 2023 Q3
Q2 2023 25,141,036 +20,024,622 +391% 10 Aug 2023 10-Q/A 25 Mar 2024 2023 Q2
Q1 2023 20,441,036 +11,066,036 +118% 27 Mar 2023 10-K/A 25 Mar 2024 2022 FY
Q4 2022 5,116,414 -4,258,586 -45% 18 Nov 2022 10-Q 18 Nov 2022 2022 Q3
Q2 2022 5,116,414 -4,258,586 -45% 09 Aug 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 9,375,000 0 0% 08 Apr 2022 10-K 08 Apr 2022 2021 FY
Q4 2021 9,375,000 -281,250 -2.9% 16 Nov 2021 10-Q 16 Nov 2021 2021 Q3
Q3 2021 9,375,000 14 Sep 2021 10-Q 14 Sep 2021 2021 Q2
Q2 2021 9,375,000 28 Jul 2021 10-K/A 28 Jul 2021 2020 FY
Q1 2021 9,375,000 30 Mar 2021 10-K/A 02 Feb 2022 2020 FY
Q4 2020 9,656,250 09 Dec 2020 10-Q 10 Dec 2020 2020 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.